Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|January 15, 1994
Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenograftsJ van Dijk, H Uemura, A J Beniers, et al.
The American Journal of Pathology|March 1, 1996
Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiationS V Litvinov, W van Driel, C M van Rhijn, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 31, 1997
Chimeric bispecific OC/TR monoclonal antibody mediates lysis of tumor cells expressing the folate-binding protein (MOv18) and displays decreased immunogenicity in patientsR M Luiten, S O Warnaar, D Sanborn, et al.
Lancet (London, England)|March 24, 1984
Hirschsprung's disease studied with monoclonal antineurofilament antibodies on tissue sectionsP Klück, G N van Muijen, A W van der Kamp, et al.
Molecular Biology Reports|September 1, 1976
Biochemical and electron microscopical evidence for the presence of oncorna viruses in spleen tissue from two patients with haematological malignanciesS O Warnaar, J Te Velde, G Van Muijen, et al.
International Journal of Cancer|February 15, 1989
Induction of tumor-cell lysis by bi-specific monoclonal antibodies recognizing renal-cell carcinoma and CD3 antigenJ van Dijk, S O Warnaar, J D van Eendenburg, et al.
The American Journal of Pathology|August 6, 1999
Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervixC J de Boer, E van Dorst, H van Krieken, et al.
The Journal of Cell Biology|January 7, 1998
Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherinsS V Litvinov, M Balzar, M J Winter, et al.
International Journal of Cancer|October 15, 1989
Bispecific antibodies reactive with the multidrug-resistance-related glycoprotein and CD3 induce lysis of multidrug-resistant tumor cellsJ Van Dijk, T Tsuruo, D M Segal, et al.
British Journal of Haematology|August 29, 1998
Chimaeric anti-interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose-escalating studyH C van Zaanen, H M Lokhorst, L A Aarden, et al.
Pageof 7